Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals

Citation
A. Sams-nielsen et al., Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals, BR J PHARM, 132(5), 2001, pp. 1145-1153
Citations number
51
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BRITISH JOURNAL OF PHARMACOLOGY
ISSN journal
00071188 → ACNP
Volume
132
Issue
5
Year of publication
2001
Pages
1145 - 1153
Database
ISI
SICI code
0007-1188(200103)132:5<1145:PEFCUI>2.0.ZU;2-#
Abstract
1 Specific mechanisms, providing reuptake of cathecholamine and amino acid neurotransmitters (e.g, serotonin and glutamate) into cells of the central nervous system are well known, whereas neuronal uptake of neuropeptide tran smitters have not previously been reported. 2 In the present study we present evidence for uptake of the 37 amino acid neuropeptide, calcitonin gene-related peptide (CGRP) into perivascular term inals of capsaicin sensitive nerve fibres, innervating the guinea-pig basil ar artery. 3 Release of CGRP from perivascular nerve terminals was obtained by capsaic in-induced vanilloid receptor-stimulation and detected as CGRP receptor-med iated dilation of isolated segments of the guinea-pig basilar artery. 4 Following three repeated capsaicin challenges, CGRP-depleted segments wer e incubated with CGRP. This caused significant reappearance of capsaicin-in duced vasodilatory responses. These responses were dependent on duration an d concentration of the preceding CGRP incubation and were inhibited by the CGRP receptor antagonist, CGRP(8-37). 5 The CGRP-re-depletion was significantly reduced when CGRP(8-37) was prese nt during the preceding CGRP incubation. Thus, presynaptic CGRP receptors a re likely to be involved in neuronal CGRP uptake. 6 Incubating the artery segments with I-125-CGRP allowed subsequent detecti on of capsaicin-induced I-125-release. 7 Immunohistochemical experiments showed that only terminal CGRP is subject to capsaicin-induced depletion in vitro, whereas CGRP-immunoreactivity end ures in the nerve fibres.